190 related articles for article (PubMed ID: 30530638)
1. Neonatal Head Circumference in Newborns With Neonatal Abstinence Syndrome.
Towers CV; Hyatt BW; Visconti KC; Chernicky L; Chattin K; Fortner KB
Pediatrics; 2019 Jan; 143(1):. PubMed ID: 30530638
[TBL] [Abstract][Full Text] [Related]
2. Head circumference in infants with nonopiate-induced neonatal abstinence syndrome.
Morimoto D; Washio Y; Hatayama K; Okamura T; Watanabe H; Yoshimoto J; Tsukahara H
CNS Spectr; 2021 Oct; 26(5):509-512. PubMed ID: 32605668
[TBL] [Abstract][Full Text] [Related]
3. Chronic opiate use in pregnancy and newborn head circumference.
Visconti KC; Hennessy KC; Towers CV; Howard BC
Am J Perinatol; 2015 Jan; 32(1):27-32. PubMed ID: 24792769
[TBL] [Abstract][Full Text] [Related]
4. Skin conductance in neonates suffering from abstinence syndrome and unexposed newborns.
Schubach NE; Mehler K; Roth B; Korsch E; Laux R; Singer D; von der Wense A; Treszl A; Hünseler C
Eur J Pediatr; 2016 Jun; 175(6):859-68. PubMed ID: 27026377
[TBL] [Abstract][Full Text] [Related]
5. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
6. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
7. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
8. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
9. Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure.
Sanlorenzo LA; Cooper WO; Dudley JA; Stratton S; Maalouf FI; Patrick SW
Hosp Pediatr; 2019 Aug; 9(8):569-575. PubMed ID: 31262946
[TBL] [Abstract][Full Text] [Related]
10. Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018.
Kelty EA; Cumming CN; Preen DB
Pharmacotherapy; 2022 May; 42(5):405-410. PubMed ID: 35342965
[TBL] [Abstract][Full Text] [Related]
11. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
12. Opioid neonatal abstinence syndrome: controversies and implications for practice.
Wolff K; Perez-Montejano R
Curr Drug Abuse Rev; 2014; 7(1):44-58. PubMed ID: 25323126
[TBL] [Abstract][Full Text] [Related]
13. The Possibility of Early Discharge for Newborns Being Monitored for Neonatal Abstinence Syndrome Based on Modified Finnegan Score Distributions.
Oji-Mmuo CN; Schaefer EW; Liao L; Kaiser JR; Sekhar DL
Clin Pediatr (Phila); 2019 Jun; 58(6):641-646. PubMed ID: 30813757
[TBL] [Abstract][Full Text] [Related]
14. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial.
Kirchner L; Graf-Rohrmeister K; Klebermass-Schrehof K; Weninger M; Jagsch R; Metz V; Unger A; Fischer G
Klin Padiatr; 2014 Sep; 226(5):274-80. PubMed ID: 25062111
[TBL] [Abstract][Full Text] [Related]
15. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
17. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
[TBL] [Abstract][Full Text] [Related]
18. Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity.
Wachman EM; Hayes MJ; Sherva R; Brown MS; Shrestha H; Logan BA; Heller NA; Nielsen DA; Farrer LA
Am J Addict; 2017 Jan; 26(1):42-49. PubMed ID: 27983768
[TBL] [Abstract][Full Text] [Related]
19. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
20. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
Jones HE; Fielder A
Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
